rs1131695

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000214.3(JAG1):​c.765C>T​(p.Tyr255Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.454 in 1,612,802 control chromosomes in the GnomAD database, including 168,141 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.43 ( 14538 hom., cov: 31)
Exomes 𝑓: 0.46 ( 153603 hom. )

Consequence

JAG1
NM_000214.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: -0.608

Publications

28 publications found
Variant links:
Genes affected
JAG1 (HGNC:6188): (jagged canonical Notch ligand 1) The jagged 1 protein encoded by JAG1 is the human homolog of the Drosophilia jagged protein. Human jagged 1 is the ligand for the receptor notch 1, the latter is involved in signaling processes. Mutations that alter the jagged 1 protein cause Alagille syndrome. Jagged 1 signalling through notch 1 has also been shown to play a role in hematopoiesis. [provided by RefSeq, Nov 2019]
JAG1 Gene-Disease associations (from GenCC):
  • Alagille syndrome due to a JAG1 point mutation
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • Charcot-Marie-Tooth disease, axonal, Type 2HH
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • tetralogy of fallot
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 20-10652589-G-A is Benign according to our data. Variant chr20-10652589-G-A is described in ClinVar as Benign. ClinVar VariationId is 143063.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.608 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.516 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
JAG1NM_000214.3 linkc.765C>T p.Tyr255Tyr synonymous_variant Exon 6 of 26 ENST00000254958.10 NP_000205.1 P78504-1Q99740

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
JAG1ENST00000254958.10 linkc.765C>T p.Tyr255Tyr synonymous_variant Exon 6 of 26 1 NM_000214.3 ENSP00000254958.4 P78504-1
JAG1ENST00000423891.6 linkn.631C>T non_coding_transcript_exon_variant Exon 4 of 25 2
JAG1ENST00000617965.2 linkn.134C>T non_coding_transcript_exon_variant Exon 1 of 17 5

Frequencies

GnomAD3 genomes
AF:
0.433
AC:
65758
AN:
151850
Hom.:
14527
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.354
Gnomad AMI
AF:
0.593
Gnomad AMR
AF:
0.459
Gnomad ASJ
AF:
0.503
Gnomad EAS
AF:
0.344
Gnomad SAS
AF:
0.534
Gnomad FIN
AF:
0.451
Gnomad MID
AF:
0.570
Gnomad NFE
AF:
0.465
Gnomad OTH
AF:
0.467
GnomAD2 exomes
AF:
0.456
AC:
114409
AN:
250970
AF XY:
0.465
show subpopulations
Gnomad AFR exome
AF:
0.349
Gnomad AMR exome
AF:
0.444
Gnomad ASJ exome
AF:
0.501
Gnomad EAS exome
AF:
0.343
Gnomad FIN exome
AF:
0.451
Gnomad NFE exome
AF:
0.467
Gnomad OTH exome
AF:
0.472
GnomAD4 exome
AF:
0.456
AC:
666247
AN:
1460834
Hom.:
153603
Cov.:
39
AF XY:
0.460
AC XY:
334168
AN XY:
726734
show subpopulations
African (AFR)
AF:
0.357
AC:
11941
AN:
33472
American (AMR)
AF:
0.444
AC:
19845
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.495
AC:
12934
AN:
26118
East Asian (EAS)
AF:
0.326
AC:
12936
AN:
39668
South Asian (SAS)
AF:
0.532
AC:
45855
AN:
86224
European-Finnish (FIN)
AF:
0.448
AC:
23895
AN:
53304
Middle Eastern (MID)
AF:
0.561
AC:
3230
AN:
5756
European-Non Finnish (NFE)
AF:
0.457
AC:
507854
AN:
1111256
Other (OTH)
AF:
0.460
AC:
27757
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
18648
37296
55945
74593
93241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15148
30296
45444
60592
75740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.433
AC:
65799
AN:
151968
Hom.:
14538
Cov.:
31
AF XY:
0.435
AC XY:
32318
AN XY:
74264
show subpopulations
African (AFR)
AF:
0.354
AC:
14674
AN:
41434
American (AMR)
AF:
0.458
AC:
7000
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.503
AC:
1747
AN:
3472
East Asian (EAS)
AF:
0.344
AC:
1768
AN:
5146
South Asian (SAS)
AF:
0.533
AC:
2574
AN:
4832
European-Finnish (FIN)
AF:
0.451
AC:
4749
AN:
10530
Middle Eastern (MID)
AF:
0.578
AC:
170
AN:
294
European-Non Finnish (NFE)
AF:
0.465
AC:
31597
AN:
67984
Other (OTH)
AF:
0.468
AC:
979
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1887
3774
5662
7549
9436
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
620
1240
1860
2480
3100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.454
Hom.:
20563
Bravo
AF:
0.428
Asia WGS
AF:
0.460
AC:
1603
AN:
3478
EpiCase
AF:
0.475
EpiControl
AF:
0.474

ClinVar

Significance: Benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Apr 04, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Department of Ophthalmology and Visual Sciences Kyoto University
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:literature only

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Alagille syndrome due to a JAG1 point mutation Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Isolated Nonsyndromic Congenital Heart Disease Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Deafness, congenital heart defects, and posterior embryotoxon Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Tetralogy of Fallot Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jun 23, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
0.42
DANN
Benign
0.90
PhyloP100
-0.61
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1131695; hg19: chr20-10633237; COSMIC: COSV54759391; COSMIC: COSV54759391; API